Cristina Birzu

Bron, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 10, 2026

Revisiting intensity normalization in brain [18F]FDG PET: What is reliable in autoimmune encephalitis?

Revisiting intensity normalization in brain [18F]FDG PET: What is reliable in autoimmune encephalitis?

Journal: NeuroImage. Clinical

Published: May 11, 2026

Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study.

Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 06, 2026

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 13, 2026

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Journal: Journal of neurology

Published: January 05, 2026

IL6 blockade: an effective approach in steroid-refractory immune checkpoint inhibitor-related neuropathies requiring ICI rechallenge-case report.

IL6 blockade: an effective approach in steroid-refractory immune checkpoint inhibitor-related neuropathies requiring ICI rechallenge-case report.

Journal: ESMO open

Published: July 21, 2025

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Journal: Neurology

Published: March 27, 2025

Abnormal Brain MRI in Anti-NMDA Receptor Encephalitis: Clinical and Prognostic Implications.

Abnormal Brain MRI in Anti-NMDA Receptor Encephalitis: Clinical and Prognostic Implications.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 25, 2025

Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports.

Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports.

Journal: European journal of neurology

Published: November 20, 2024

Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma.

Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 10, 2024

Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study.

Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort study.

Journal: The Lancet regional health. Europe

Published: April 07, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026